Head-to-head · WeighScore
HumeCare+ vs Ryze Rx
The verdict
HumeCare+ takes it — 58.6/100 to 58.2/100, but only just.
HumeCare+ grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HumeCare+ is the GLP-1 telehealth program from Hume Health, the body-composition scale company. Ryze Rx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | HumeCare+ | Ryze Rx |
|---|---|---|
| WeighScore | 58.6/100 | 58.2/100 |
| Grade | C | C |
| Scorecard rank | #366 | #376 |
| Semaglutide | $199/mo (starting dose, compounded) | $199/mo (starting dose, 3 month plan, compounded) |
| Tirzepatide | Not disclosed | $199/mo (starting dose, 3 month plan, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #366 · C
Strengths
- Pairs compounded semaglutide with continuous body-composition tracking (lose fat, preserve muscle)
- Includes a Hume Pod body-composition device at no extra cost
- From $199/mo, billed monthly, cancel anytime
- Backed by Hume Health, an established body-composition scale brand
- Clinician-prescribed and monitored with weekly tracking
Where it loses points
- Final medication pricing is gated behind an intake quiz
- Only semaglutide is shown on the marketing site (tirzepatide not confirmed)
- Prescribing medical group and pharmacy partner not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Graded #376 · C
Strengths
- Compounded semaglutide and tirzepatide both $199/mo, with $499/$799 three-month bundles
- Physician consultation, ongoing clinical support and discreet shipping included with each prescription
- Broad catalog beyond GLP-1: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide and more)
- Free shipping, 24hr prescription turnaround, FSA/HSA eligible; care advertised in all 50 states
Where it loses points
- Terms, Privacy Policy and HIPAA notice are dead links - no legal entity, refund policy or governing law disclosed
- Pharmacy partners not named - only 'US-licensed compounding pharmacies'
- Homepage advertises GLP-1s 'from $149/mo' but the catalog lists $199/mo
- On-site '4.9/5, 2,400+ reviews' is self-reported, not an independently verified rating
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.